About EditCo
EditCo is a Healthcare company based in Redwood City (United States) founded in 2024 by John Tan and Travis Maures. It provides CRISPR reagents, kits, and engineered cells for genome editing research. It operates on a B2B model. Its chief executive, as recorded, is John Tan. Its website editco.bio draws about 18 thousand monthly visits. EditCo offers products and services including Gene Knockout Kits, Edited Immortalized Cells, Arrayed CRISPR sgRNA Libraries, Knockout iPS Cells, and CRISPR Nucleases and Controls. Its focus areas include Life Sciences, Cell Engineering, iPS Cells and Disease Modeling. Its competitors include GenScript and Fluent BioSciences; 2 of its 2 listed competitors have raised funding.
Company details
EditCo specializes in genome engineering through CRISPR technology, delivering products like gene knockout kits and edited cell lines for applications in oncology and immunology. They provide high-efficiency services for immortalized cells, iPS cells, and primary cells to support scientific research. With a focus on accuracy and reliability, EditCo partners with researchers globally to advance gene editing solutions.
- Headquarters Redwood City, United States
- Founders John Tan, Travis Maures
- SectorsHealthcare
- Website editco.bio
- Social LinkedIn X
Products & Services of EditCo
EditCo offers a comprehensive portfolio of products and services, including Gene Knockout Kits, Edited Immortalized Cells, Arrayed CRISPR sgRNA Libraries, Knockout iPS Cells, and CRISPR Nucleases and Controls.
Kits for efficient gene knockouts in human and mouse cells.
Ready-to-use cells with precise edits for research applications.
Libraries for reliable gene knockout screening experiments.
Edited iPS cells for disease modeling and drug discovery.
Tools to complete CRISPR experiments with high efficiency.
People of EditCo
28 people are tracked at EditCo (12 in leadership, 16 in team).
| Name | Role | Group |
|---|---|---|
John Tan | Co-Founder, CEO | Leadership |
Travis Maures | Co-Founder, CSO | Leadership |
Wes Douwes | Vice President Finance | Leadership |
Zofia Świątczak | Head Of Sales - Europe | Leadership |
Shelly Peariso | Head Of Commercial, Global | Leadership |
Andreia Gianotti Sommer | Director, Scientific Operations | Leadership |
Montse Morell | Director, Scientific Development | Leadership |
Prachi Gupta | Director, Scientific Support And Customer Success | Leadership |
Travis H. | Director Of Product Management | Leadership |
Paul Dabrowski | Co-founder | Leadership |
Rob Hart | Founding Investor, Director | Leadership |
Deval Lashkari | Director Board Of Directors | Leadership |
Phil Byun | Global Strategic Account Manager | Team |
Nano Schmidt | Global Strategic Account Manager | Team |
Niraj Shah | Global Strategic Account Manager | Team |
Pauline Germaux | Senior Lead | Team |
Jonathan Elizalde | Manager, Scientific Operations, Production | Team |
Dr. Melanie Maerken | Senior Technical Specialist And Project Manager | Team |
Anna King | Senior Manager, Process Science | Team |
Clark Ho | Senior Scientist, Engineered Cells | Team |
8 more people are available in the full profile.
Complete people profiles for EditCo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of EditCo
EditCo has 2 listed competitors in our database, 2 of them funded. They include GenScript and Fluent BioSciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | Proprietary reagents for single-cell genetic analysis are developed. |
Detailed competitors of EditCo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EditCo
The website of EditCo (editco.bio) receives about 18.3K visits a month.
- Monthly visits18.3K
▼ 12.8% vs previous month
Websites whose visitors overlap most with EditCo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| synthego.com | 85% | 100.3K | #405,738 | View details | |
| ixcellsbiotech.com | 84% | 14.2K | #1,627,815 | View details |
Top companies in Cell Therapy
3 companies that operate in the same segment as EditCo (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Editco
Complete news archive for EditCo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EditCo
EditCo was founded in 2024.
EditCo is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
John Tan is the CEO of EditCo, as recorded in our data. They have also founded this company.
EditCo specializes in genome engineering through CRISPR technology, delivering products like gene knockout kits and edited cell lines for applications in oncology and immunology. They provide high-efficiency services for immortalized cells, iPS cells, and primary cells to support scientific research. With a focus on accuracy and reliability, EditCo partners with researchers globally to advance gene editing solutions.
EditCo's top competitors include GenScript and Fluent BioSciences.
EditCo offers Gene Knockout Kits, Edited Immortalized Cells, Arrayed CRISPR sgRNA Libraries, Knockout iPS Cells, and CRISPR Nucleases and Controls.